TLGWBR provides a strong prognostic indicator and could be an important guide for making treatment decisions in advanced lung adenocarcinoma patients with EGFR mutation status; however, it cannot be used to further stratify the risk of worse OS for patients with the EGFR mutation. Here, EGFR is linked to lung adenocarcinoma.